US2008113362A1PendingUtilityA1

METHODS FOR ISOLATING AND CHARACTERIZING ENDOGENOUS mRNA-PROTEIN (mRNP) COMPLEXES

Assignee: RIBONOMICS INCPriority: Dec 28, 1999Filed: Oct 30, 2007Published: May 15, 2008
Est. expiryDec 28, 2019(expired)· nominal 20-yr term from priority
G01N 33/5023C12Q 1/6809C12Q 1/6804C07H 21/02G01N 33/6845C12Q 2600/158G01N 33/68G01N 33/6803G01N 33/5008G01N 33/5308
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Cellular mRNA-protein (mRNP) complexes are partitioned in vivo by contacting a biological sample with at least one ligand that specifically binds at least one component of a mRNP complex. Suitable biological samples comprise at least one mRNA-protein (mRNP) complex and include cell cultures, cell extracts, and whole tissue, including tumor tissue. Ligands include antibodies that specifically bind RNA-binding or RNA-associated proteins present in the mRNP complex. The mRNP complex is separated by binding the ligand with a binding molecule specific for the ligand, where the binding molecule is attached to a solid support. The mRNP complex is collected by removing the mRNP complex from the solid support. After collecting the mRNP complex, the mRNA bound within the complex may be characterized and identified. Subsets of the total mRNA population of a cell may accordingly be characterized, and a gene expression profile of the cell obtained.

Claims

exact text as granted — not AI-modified
1 . A method of characterizing an RNA-protein complex, the method comprising:
 a) expressing in vivo an epitope-tagged RNA-binding protein thereby forming an RNA-protein complex in a cell,   b) lysing the cell to produce a lysate;   c) contacting the lysate with a ligand that specifically binds to the epitope tag;   d) isolating the RNA-protein complex from the lysate; and   e) identifying at least one RNA and/or at least one protein, other than the epitope-tagged protein, from the isolated the RNA-protein complex;   wherein the nucleic acid encoding the epitope-tagged RNA-binding protein is under the control of a tissue-specific promoter.

Join the waitlist — get patent alerts

Track US2008113362A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.